Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Genetics”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT00140894
What this trial is testing

Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)

Who this might be right for
Adenomatous Polyposis Coli
Merck Sharp & Dohme LLC 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT04320888
What this trial is testing

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma+35 more
National Cancer Institute (NCI) 1
Large-scale testing (Phase 3)Ended earlyNCT04308395
What this trial is testing

Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)

Who this might be right for
Basal Cell Nevus Syndrome
Sol-Gel Technologies, Ltd. 108
Early research (Phase 1)UnknownNCT04432857
What this trial is testing

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

Who this might be right for
Triple-negative Breast CancerNSCLC, Squamous or Non-SquamousUrothelial Carcinoma of the Bladder+2 more
Adlai Nortye Biopharma Co., Ltd. 63
Not applicableStudy completedNCT05735977
What this trial is testing

Nephrogreen. Appearances of Exvivo Renal Tumours Under Near-infrared

Who this might be right for
Wilms TumorRenal Cancer
Birmingham Women's and Children's NHS Foundation Trust 12
Not applicableLooking for participantsNCT06712095
What this trial is testing

Video Capsule Examination in Patients With Lynch Syndrome

Who this might be right for
Lynch SyndromeLi Fraumeni SyndromePTEN Hamartoma Syndrome+7 more
Royal Marsden NHS Foundation Trust 25
Not applicableEnded earlyNCT00466375
What this trial is testing

Genetic Basis of Hemangiomas

Who this might be right for
Hemangioma, Vascular Anomalies
Medical College of Wisconsin 300
Not applicableUnknownNCT04972409
What this trial is testing

Value of Information of Secondary dAta in ONCOGEnetics

Who this might be right for
CancerGenetic PredispositionSecondary Fundings
Centre Georges Francois Leclerc 70
Not applicableWithdrawnNCT02309632
What this trial is testing

Pancreatic Cancer Screening of High-Risk Individuals in Arkansas

Who this might be right for
Pancreatic NeoplasmsPeutz-Jegher's SyndromeBRCA1 Gene Mutation+5 more
University of Arkansas
Testing effectiveness (Phase 2)Study completedNCT02934256
What this trial is testing

Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

Who this might be right for
Vestibular SchwannomaNeurofibromatosis Type 2
Li Peng 10
Testing effectiveness (Phase 2)Looking for participantsNCT03266653
What this trial is testing

EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection

Who this might be right for
Epstein-Barr Virus InfectionsPrimary Immune Deficiency Disorder
New York Medical College 20
Testing effectiveness (Phase 2)UnknownNCT00319007
What this trial is testing

Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis

Who this might be right for
Adenomatous Polyposis Coli
Radboud University Medical Center 30
Large-scale testing (Phase 3)Study completedNCT00035334
What this trial is testing

Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis

Who this might be right for
Secondary (AA) AmyloidosisRheumatoid ArthritisNephrotic Syndrome+3 more
Bellus Health Inc. - a GSK company 150
Not applicableUnknownNCT05158712
What this trial is testing

Genetic Factors and Pheochromocytomas in Neoplasia Type 2

Who this might be right for
NeoplasiaPheochromocytoma
Assistance Publique Hopitaux De Marseille 14
Not applicableLooking for participantsNCT05929365
What this trial is testing

Innovative Approach to Detect Recurrent Colorectal Lesions With Surveillance Via Mutation Analysis & Clinical Phenotype

Who this might be right for
Predictive Cancer Model
Military University Hospital, Prague 200
Not applicableStudy completedNCT00001500
What this trial is testing

Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits

Who this might be right for
Acquired Immunodeficiency SyndromeAlcoholismHIV Infection+2 more
National Cancer Institute (NCI) 4,500
Not applicableEnded earlyNCT03765736
What this trial is testing

Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Rectal AdenocarcinomaStage III Colon Cancer AJCC v8+17 more
Academic and Community Cancer Research United 199
Not applicableWithdrawnNCT03041571
What this trial is testing

Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Students

Who this might be right for
Narrative MedicineChronic DiseaseTerminal Illness+6 more
University of Florida
Not applicableUnknownNCT05889481
What this trial is testing

Morphological, Genetic and Tumour Microenvironment Characterisation in Uveal Melanoma

Who this might be right for
Uveal Melanoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100
Not applicableLooking for participantsNCT07498829
What this trial is testing

Population Based Germline Testing for Early Detection and Prevention of Cancer

Who this might be right for
Breast Cancer RiskOvarian Cancer RiskCancer Gene Mutation
Queen Mary University of London 6,000
Next Page